Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
The Journal of Rheumatology
|
March 1, 1994
Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy
B D Warady, C B Lindsley, F G Robinson, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
December 1, 1989
Improving compliance with prednisone therapy in pediatric patients with rheumatic disease
K B Pieper, M A Rapoff, M R Purviance, et al.
JAMA
|
October 3, 1980
Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis
H L Harrison, M A Linshaw, C B Lindsley, et al.
The Nebraska Medical Journal
|
March 1, 1995
Evaluation of growth hormone secretion in children with juvenile rheumatoid arthritis and short stature
R J Hopp, J Degan, K Corley, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
June 1, 1996
Chronic pain and emotional distress in children and adolescents
J W Varni, M A Rapoff, S A Waldron, et al.
Journal of Behavioral Medicine
|
December 1, 1996
Effects of perceived stress on pediatric chronic pain
J W Varni, M A Rapoff, S A Waldron, et al.
Journal of Pediatric Psychology
|
April 1, 1996
Assessing chronic musculoskeletal pain associated with rheumatic disease: further validation of the pediatric pain questionnaire
R A Gragg, M A Rapoff, M B Danovsky, et al.
Arthritis and Rheumatism
|
November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group
L G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)
|
September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy
A M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism
|
October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group
D J Lovell, C B Lindsley, R M Rennebohm, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
The Journal of Rheumatology
|
March 1, 1994
Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy
B D Warady, C B Lindsley, F G Robinson, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
December 1, 1989
Improving compliance with prednisone therapy in pediatric patients with rheumatic disease
K B Pieper, M A Rapoff, M R Purviance, et al.
JAMA
|
October 3, 1980
Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis
H L Harrison, M A Linshaw, C B Lindsley, et al.
The Nebraska Medical Journal
|
March 1, 1995
Evaluation of growth hormone secretion in children with juvenile rheumatoid arthritis and short stature
R J Hopp, J Degan, K Corley, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
June 1, 1996
Chronic pain and emotional distress in children and adolescents
J W Varni, M A Rapoff, S A Waldron, et al.
Journal of Behavioral Medicine
|
December 1, 1996
Effects of perceived stress on pediatric chronic pain
J W Varni, M A Rapoff, S A Waldron, et al.
Journal of Pediatric Psychology
|
April 1, 1996
Assessing chronic musculoskeletal pain associated with rheumatic disease: further validation of the pediatric pain questionnaire
R A Gragg, M A Rapoff, M B Danovsky, et al.
Arthritis and Rheumatism
|
November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group
L G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)
|
September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy
A M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism
|
October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group
D J Lovell, C B Lindsley, R M Rennebohm, et al.
Page
of 4